Office of Cooperative Research Hosts: "Pitch Your Biotech Idea for Blavatnik and VC Funding: with Colleen Cuffaro"
Join us for this info session to help you get funded, brought to you by the Blavatnik Fund for Innovation at Yale.
Lunch will be provided
For this session we're featuring Colleen Cuffaro of Canaan. Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. Read her bio below:
About Colleen Cuffaro:
Colleen’s investment focus is early stage biopharmaceutical companies. Her interests lie in transformative medical technologies that deliver value to providers and patients alike. In her time at Canaan, Colleen helped launch the Canaan-Yale Fellowship program. Colleen previously worked as a chemist at Pharmaceutical Manufacturing and Research Services, Inc. She holds a Ph.D. in Cellular and Molecular Physiology from Yale University and a B.A. in Chemistry from the University of Pennsylvania.
About the Blavatnik Fund for Innovation at Yale
The Blavatnik Fund for Innovation at Yale bridges the gap between innovative, early-stage life science research and successful development of high-impact biomedical products. Our integrated approach combines essential funding with development and business expertise, leading to commercial partnerships that bring forth new biomedical discoveries that create value and benefit society.
Canaan PartnersColleen Cuffaro, PhDPrincipal